These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 14626953)

  • 1. U.S. near accord with WTO over generic drug access.
    AIDS Policy Law; 2003 Sep; 18(17):1. PubMed ID: 14626953
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic drugs. U.S. makes concession on WTO drug agreement.
    AIDS Policy Law; 2003 Jul; 18(13):1. PubMed ID: 12913964
    [No Abstract]   [Full Text] [Related]  

  • 3. International. Rights group: U.S. blocking access to generic AIDS drugs.
    AIDS Policy Law; 2004 Apr; 19(7):1, 4. PubMed ID: 15124593
    [No Abstract]   [Full Text] [Related]  

  • 4. Affordable drug access for developing countries.
    Highleyman L
    BETA; 2001; 14(2):12-25. PubMed ID: 11785481
    [No Abstract]   [Full Text] [Related]  

  • 5. Emory law school conference tackles access to generic AIDS drugs.
    AIDS Policy Law; 2003 Apr; 18(8):4. PubMed ID: 12739488
    [No Abstract]   [Full Text] [Related]  

  • 6. TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.
    't Hoen E
    Chic J Int Law; 2002; 3(1):27-46. PubMed ID: 15709298
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug access. WTO, Clinton Foundation cut red tape over drug dispute.
    AIDS Policy Law; 2007 Aug; 22(16):2. PubMed ID: 18203380
    [No Abstract]   [Full Text] [Related]  

  • 8. Poor countries should use flexibility in global trade agreement to improve access to antiretrovirals, says report.
    Zarocostas J
    BMJ; 2011 Mar; 342():d1677. PubMed ID: 21411492
    [No Abstract]   [Full Text] [Related]  

  • 9. U.S. is lone holdout on drug access vote.
    AIDS Policy Law; 2003 Jan; 18(1):1. PubMed ID: 12569860
    [No Abstract]   [Full Text] [Related]  

  • 10. Africa, access, and patents: moving fast.
    James JS
    AIDS Treat News; 1999 Jul; (No 322):5-8. PubMed ID: 11366567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of low cost AIDS drugs to continue in Brazil.
    Reprod Health Matters; 2001 Nov; 9(18):178. PubMed ID: 11803899
    [No Abstract]   [Full Text] [Related]  

  • 12. . . . and Brazilian AIDS programme threatened by US trade action.
    Int J Epidemiol; 2001 Apr; 30(2):413. PubMed ID: 11369751
    [No Abstract]   [Full Text] [Related]  

  • 13. Physicians say generic AIDS drugs don't threaten R&D.
    AIDS Policy Law; 2002 Mar; 17(6):4. PubMed ID: 12004757
    [No Abstract]   [Full Text] [Related]  

  • 14. Bush accused of pressuring countries to stop producing generic drugs.
    Fleck F
    BMJ; 2004 Jul; 329(7459):192. PubMed ID: 15271829
    [No Abstract]   [Full Text] [Related]  

  • 15. Kenya says yes to generic ARVs but fails to win Global Fund cash.
    Njoroge J
    Bull World Health Organ; 2002; 80(7):608. PubMed ID: 12163933
    [No Abstract]   [Full Text] [Related]  

  • 16. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 17. Will they deliver treatment access?: WTO rules and Canada's law on generic medicine exports.
    Elliott R
    HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):13-6. PubMed ID: 17373059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD; Narayanan P
    Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
    [No Abstract]   [Full Text] [Related]  

  • 19. U.S. blocks trade agreement on generic drug access in poor countries.
    James JS
    AIDS Treat News; 2002 Dec; (386):4-6. PubMed ID: 12569874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trade agreements, intellectual property, and the role of the World Bank in improving access to medicines in developing countries.
    Rovira J
    Yale J Health Policy Law Ethics; 2004; 4(2):401-13. PubMed ID: 15536921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.